Why fast-growing Philadelphia biotech firm Imvax picked the iconic Curtis building for its new HQ
Philadelphia Business Journal
Imvax expected to host an event in April or May to unveil its new headquarters at The Curtis in the Old City section of Philadelphia, but the ongoing pandemic scuttled those plans.
“Covid-19 clearly got in the way,” said John Furey, the former Spark Therapeutics executive who was hired as CEO of Imvax last year. “Once we see the light at the end of the tunnel with all of this, we’ll do something” to show off the new space.
The company previously operated out of a small office in Chestnut Hill and took the 17,000 square feet of space at the iconic Curtis building to keep up with its expansion.
Click HERE to read more.